ARID1A is mutated in ~8% of all cancers, with clear cell ovarian carcinoma (CCOC) presenting the highest incidence of ARID1A loss at > 50% of cases [1,2]. This evidence concerns the gene ARID1A and ovarian clear cell cancer.